3-25598334-ATCT-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PM4_SupportingBS2

The NM_001330700.2(TOP2B):​c.4851_4853delAGA​(p.Glu1617del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000838 in 1,610,400 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000082 ( 1 hom. )

Consequence

TOP2B
NM_001330700.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.47
Variant links:
Genes affected
TOP2B (HGNC:11990): (DNA topoisomerase II beta) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_001330700.2. Strenght limited to Supporting due to length of the change: 1aa.
BS2
High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TOP2BNM_001330700.2 linkuse as main transcriptc.4851_4853delAGA p.Glu1617del disruptive_inframe_deletion 36/36 ENST00000264331.9 NP_001317629.1 Q02880-1
TOP2BNM_001068.3 linkuse as main transcriptc.4836_4838delAGA p.Glu1612del disruptive_inframe_deletion 36/36 NP_001059.2 Q02880-2Q59H80
TOP2BXM_011534057.4 linkuse as main transcriptc.4740_4742delAGA p.Glu1580del disruptive_inframe_deletion 35/35 XP_011532359.1
TOP2BXM_047448821.1 linkuse as main transcriptc.4725_4727delAGA p.Glu1575del disruptive_inframe_deletion 35/35 XP_047304777.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TOP2BENST00000264331.9 linkuse as main transcriptc.4851_4853delAGA p.Glu1617del disruptive_inframe_deletion 36/365 NM_001330700.2 ENSP00000264331.4 Q02880-1

Frequencies

GnomAD3 genomes
AF:
0.0000985
AC:
15
AN:
152238
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000895
AC:
22
AN:
245914
Hom.:
0
AF XY:
0.0000825
AC XY:
11
AN XY:
133318
show subpopulations
Gnomad AFR exome
AF:
0.000324
Gnomad AMR exome
AF:
0.0000595
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000203
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000803
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000823
AC:
120
AN:
1458044
Hom.:
1
AF XY:
0.0000800
AC XY:
58
AN XY:
724982
show subpopulations
Gnomad4 AFR exome
AF:
0.0000900
Gnomad4 AMR exome
AF:
0.0000681
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000188
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000865
Gnomad4 OTH exome
AF:
0.0000332
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152356
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0000721
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000102
EpiCase
AF:
0.000274
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 31, 2023This variant, c.4836_4838del, results in the deletion of 1 amino acid(s) of the TOP2B protein (p.Glu1612del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs769246397, gnomAD 0.02%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with TOP2B-related conditions. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767895836; hg19: chr3-25639825; API